Literature DB >> 32613028

Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms.

Kate A Harrington1, Travis L Williams2, Sharon A Lawrence3, Jayasree Chakraborty3, Mohammad A Al Efishat3, Marc A Attiyeh3, Gokce Askan4, Yuting Chou3, Alessandra Pulvirenti3, Caitlin A McIntyre3, Mithat Gonen2, Olca Basturk4, Vinod P Balachandran3, T Peter Kingham3, Michael I D'Angelica3, William R Jarnagin3, Jeffrey A Drebin3, Richard K Do1, Peter J Allen3, Amber L Simpson5.   

Abstract

Purpose: Our paper contributes to the burgeoning field of surgical data science. Specifically, multimodal integration of relevant patient data is used to determine who should undergo a complex pancreatic resection. Intraductal papillary mucinous neoplasms (IPMNs) represent cystic precursor lesions of pancreatic cancer with varying risk for malignancy. We combine previously defined individual models of radiomic analysis of diagnostic computed tomography (CT) with protein markers extracted from the cyst fluid to create a unified prediction model to identify high-risk IPMNs. Patients with high-risk IPMN would be sent for resection, whereas patients with low-risk cystic lesions would be spared an invasive procedure. Approach: Retrospective analysis of prospectively acquired cyst fluid and CT scans was undertaken for this study. A predictive model combining clinical features with a cyst fluid inflammatory marker (CFIM) was applied to patient data. Quantitative imaging (QI) features describing radiomic patterns predictive of risk were extracted from scans. The CFIM model and QI model were combined into a single predictive model. An additional model was created with tumor-associated neutrophils (TANs) assessed by a pathologist at the time of resection.
Results: Thirty-three patients were analyzed (7 high risk and 26 low risk). The CFIM model yielded an area under the curve (AUC) of 0.74. Adding the QI model improved performance with an AUC of 0.88. Combining the CFIM, QI, and TAN models further increased performance to an AUC of 0.98. Conclusions: Quantitative analysis of routinely acquired CT scans combined with CFIMs provides accurate prediction of risk of pancreatic cancer progression. Although a larger cohort is needed for validation, this model represents a promising tool for preoperative assessment of IPMN.
© 2020 Society of Photo-Optical Instrumentation Engineers (SPIE).

Entities:  

Keywords:  cyst fluid; intraductal papillary mucinous neoplasms; pancreas; quantitative image analysis; radiomics

Year:  2020        PMID: 32613028      PMCID: PMC7315109          DOI: 10.1117/1.JMI.7.3.031507

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  34 in total

1.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.

Authors:  Masao Tanaka; Carlos Fernández-del Castillo; Volkan Adsay; Suresh Chari; Massimo Falconi; Jin-Young Jang; Wataru Kimura; Philippe Levy; Martha Bishop Pitman; C Max Schmidt; Michio Shimizu; Christopher L Wolfgang; Koji Yamaguchi; Kenji Yamao
Journal:  Pancreatology       Date:  2012-04-16       Impact factor: 3.996

2.  Comparison of the international consensus guidelines for predicting malignancy in intraductal papillary mucinous neoplasms.

Authors:  Suguru Yamada; Tsutomu Fujii; Kenta Murotani; Mitsuro Kanda; Hiroyuki Sugimoto; Goro Nakayama; Masahiko Koike; Michitaka Fujiwara; Akimasa Nakao; Yasuhiro Kodera
Journal:  Surgery       Date:  2015-10-23       Impact factor: 3.982

3.  Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.

Authors:  Minoru Tada; Takao Kawabe; Masatoshi Arizumi; Osamu Togawa; Saburo Matsubara; Natsuyo Yamamoto; Yosuke Nakai; Naoki Sasahira; Kenji Hirano; Takeshi Tsujino; Keisuke Tateishi; Hiroyuki Isayama; Nobuo Toda; Haruhiko Yoshida; Masao Omata
Journal:  Clin Gastroenterol Hepatol       Date:  2006-09-18       Impact factor: 11.382

4.  Tumor-infiltrating neutrophils in pancreatic neoplasia.

Authors:  Michelle D Reid; Olca Basturk; Duangpen Thirabanjasak; Ralpha H Hruban; David S Klimstra; Pelin Bagci; Deniz Altinel; Volkan Adsay
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

5.  Pancreatic cysts: depiction on single-shot fast spin-echo MR images.

Authors:  Xiao-Ming Zhang; Donald G Mitchell; Masako Dohke; George A Holland; Laurence Parker
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

6.  CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jayasree Chakraborty; Abhishek Midya; Lior Gazit; Marc Attiyeh; Liana Langdon-Embry; Peter J Allen; Richard K G Do; Amber L Simpson
Journal:  Med Phys       Date:  2018-09-27       Impact factor: 4.071

7.  Cytology from pancreatic cysts has marginal utility in surgical decision-making.

Authors:  Ajay V Maker; Linda S Lee; Chandrajit P Raut; Thomas E Clancy; Richard S Swanson
Journal:  Ann Surg Oncol       Date:  2008-09-03       Impact factor: 5.344

8.  IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection.

Authors:  Giovanni Marchegiani; Mari Mino-Kenudson; Klaus Sahora; Vicente Morales-Oyarvide; Sarah Thayer; Cristina Ferrone; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-Del Castillo
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

9.  Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms.

Authors:  Satoshi Tanno; Yasuhiro Nakano; Kazuya Koizumi; Yoshiaki Sugiyama; Kazumasa Nakamura; Junpei Sasajima; Tomoya Nishikawa; Yusuke Mizukami; Nobuyuki Yanagawa; Tsuneshi Fujii; Toshikatsu Okumura; Takeshi Obara; Yutaka Kohgo
Journal:  Pancreas       Date:  2010-01       Impact factor: 3.327

10.  Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Jae Seung Kang; Taesung Park; Youngmin Han; Seungyeon Lee; Heeju Lim; Hyeongseok Kim; Se Hyung Kim; Wooil Kwon; Sun-Whe Kim; Jin-Young Jang
Journal:  Ann Surg Treat Res       Date:  2019-07-29       Impact factor: 1.859

View more
  4 in total

Review 1.  Radiomics for the Diagnosis and Differentiation of Pancreatic Cystic Lesions.

Authors:  Jorge D Machicado; Eugene J Koay; Somashekar G Krishna
Journal:  Diagnostics (Basel)       Date:  2020-07-21

Review 2.  Recent advances in the diagnostic evaluation of pancreatic cystic lesions.

Authors:  Devarshi R Ardeshna; Troy Cao; Brandon Rodgers; Chidiebere Onongaya; Dan Jones; Wei Chen; Eugene J Koay; Somashekar G Krishna
Journal:  World J Gastroenterol       Date:  2022-02-14       Impact factor: 5.374

Review 3.  Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.

Authors:  Kiersten Preuss; Nate Thach; Xiaoying Liang; Michael Baine; Justin Chen; Chi Zhang; Huijing Du; Hongfeng Yu; Chi Lin; Michael A Hollingsworth; Dandan Zheng
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

4.  Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas.

Authors:  Jennifer B Permuth; Shraddha Vyas; Jiannong Li; Dung-Tsa Chen; Daniel Jeong; Jung W Choi
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.